Pacific Biosciences of California, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2014
Total Assets: $124.4M
Liabilities Breakdown FY2014
Total Liabilities: $69.4M
Asset Breakdown
Total Assets: $124.4M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $36.4M | 29.3% |
| Accounts Receivable | $3.4M | 2.7% |
| Inventory | $11.3M | 9.1% |
| Property, Plant & Equipment | $6.6M | 5.3% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $66.6M | 53.5% |
Liabilities Breakdown
Total Liabilities: $69.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $5.6M | 8.1% |
| Long-Term Debt | $14.1M | 20.3% |
| Other Liabilities | $49.7M | 71.6% |